MarketCap
Facebook
X
Telegram
Oragenics PEG Ratio | OGEN
Annual PEG Ratio Oragenics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.00446 | -0.000401 | -0.000485 | -0.00149 | -0.00017 | - | -0.0208 | -0.0332 | -0.118 | -0.0865 | 0.0322 | -0.0691 | -0.275 | -0.0983 | -0.165 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.0322 | -0.275 | -0.06 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Adagene
ADAG
|
0.612 | $ 1.99 | -1.73 % | $ 117 M |  China |
 |
Benitec Biopharma
BNTC
|
-0.0443 | $ 9.51 | 10.07 % | $ 443 M |  USA |
 |
Denali Therapeutics
DNLI
|
0.0634 | $ 20.09 | 1.88 % | $ 3.47 B | USA |
 |
Amarin Corporation plc
AMRN
|
0.633 | $ 11.55 | -0.2 % | $ 4.79 B |  Irlanda |
 |
Editas Medicine
EDIT
|
-1.63 | $ 2.57 | 0.59 % | $ 228 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
-0.339 | $ 29.4 | 4.0 % | $ 1.7 B | USA |
 |
Cue Biopharma
CUE
|
0.0442 | $ 18.93 | 5.11 % | $ 1.79 B | USA |
 |
Equillium
EQ
|
-2.61 | $ 1.54 | 15.79 % | $ 88.2 M | USA |
 |
Black Diamond Therapeutics
BDTX
|
-0.000262 | $ 1.73 | 4.22 % | $ 98.4 M | USA |
 |
Pliant Therapeutics
PLRX
|
0.0197 | $ 0.81 | -0.12 % | $ 49.7 M | USA |
 |
Abeona Therapeutics
ABEO
|
-0.00404 | $ 4.18 | 6.78 % | $ 221 M | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
-0.0413 | $ 4.36 | 8.19 % | $ 706 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
-0.0844 | $ 21.22 | -0.09 % | $ 3.57 B | USA |
 |
PainReform Ltd.
PRFX
|
-0.00083 | $ 0.85 | 11.62 % | $ 551 K |  Israel |
 |
Jazz Pharmaceuticals plc
JAZZ
|
0.07 | $ 235.01 | 3.38 % | $ 14.3 B | Irlanda |
 |
Atossa Therapeutics
ATOS
|
-0.00563 | $ 2.14 | 5.94 % | $ 18.4 M | USA |
 |
Liquidia Corporation
LQDA
|
0.000305 | $ 44.53 | 0.08 % | $ 3.83 B | USA |
 |
Cleveland BioLabs, Inc.
CBLI
|
-1.36 | - | -7.31 % | $ 49 M | USA |
 |
Five Prime Therapeutics, Inc.
FPRX
|
-0.176 | - | - | $ 1.77 B | USA |
 |
ADC Therapeutics SA
ADCT
|
0.0711 | $ 1.59 | -2.16 % | $ 202 M |  Schweiz |
 |
Harmony Biosciences Holdings
HRMY
|
0.207 | $ 33.1 | 1.96 % | $ 1.9 B | USA |
 |
Ardelyx
ARDX
|
1.87 | $ 2.88 | -3.85 % | $ 694 M | USA |
 |
Akebia Therapeutics
AKBA
|
1.03 | $ 0.39 | -7.57 % | $ 100 M | USA |
 |
Alector
ALEC
|
-0.0395 | $ 2.3 | 9.81 % | $ 237 M | USA |
 |
ALX Oncology Holdings
ALXO
|
-1.1 | $ 1.16 | 0.43 % | $ 62.2 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
-0.293 | $ 20.13 | 3.5 % | $ 6.31 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
1.34 | $ 3.65 | -0.54 % | $ 699 M |  Canada |
 |
Agenus
AGEN
|
0.4 | $ 7.13 | 10.71 % | $ 212 M | USA |
 |
AbCellera Biologics
ABCL
|
0.17 | $ 11.89 | 6.83 % | $ 3.55 B | Canada |
 |
Artelo Biosciences
ARTL
|
-0.000128 | $ 1.98 | -6.62 % | $ 375 K | USA |
 |
Immatics N.V.
IMTX
|
2.14 K | $ 6.36 | 2.91 % | $ 778 M |  Germany |
 |
Aptevo Therapeutics
APVO
|
-0.000004 | $ 1.24 | -2.36 % | $ 391 K | USA |
 |
Aligos Therapeutics
ALGS
|
-0.0104 | $ 4.14 | -8.2 % | $ 40.9 M | USA |
 |
Aclaris Therapeutics
ACRS
|
2.62 | $ 3.9 | 8.03 % | $ 478 M | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
2.84 | $ 27.98 | 4.29 % | $ 4.25 B | USA |
 |
Cellectar Biosciences
CLRB
|
-0.00121 | $ 1.24 | 7.83 % | $ 3.23 M | USA |
|
Larimar Therapeutics
LRMR
|
0.477 | $ 2.4 | 3.23 % | $ 199 M | USA |
 |
Biofrontera AG
BFRA
|
0.312 | - | -8.24 % | $ 105 M | Germany |
 |
Catabasis Pharmaceuticals, Inc.
CATB
|
0.0518 | - | -6.97 % | $ 657 M | USA |
 |
Capricor Therapeutics
CAPR
|
-0.494 | $ 8.97 | 4.3 % | $ 417 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
0.154 | $ 28.5 | 3.04 % | $ 1.33 B | USA |
 |
China Biologic Products Holdings, Inc.
CBPO
|
2.73 | - | 1.68 % | $ 4.65 B | China |
 |
Aquestive Therapeutics
AQST
|
-0.64 | $ 3.6 | -1.64 % | $ 385 M | USA |
 |
Jaguar Health
JAGX
|
-0.00477 | $ 0.4 | -2.16 % | $ 933 K | USA |
 |
Arvinas
ARVN
|
31.3 | $ 6.41 | -2.14 % | $ 454 M | USA |
 |
Cerus Corporation
CERS
|
0.951 | $ 2.03 | -4.93 % | $ 387 M | USA |
 |
Beam Therapeutics
BEAM
|
-1.32 | $ 26.43 | 2.15 % | $ 2.61 B | USA |
 |
Fortress Biotech
FBIO
|
0.00811 | $ 1.86 | 0.82 % | $ 51.9 M | USA |
 |
Inhibrx
INBX
|
-0.158 | $ 84.71 | 5.52 % | $ 3.99 B | USA |
 |
Entera Bio Ltd.
ENTX
|
-0.0685 | $ 3.16 | 5.69 % | $ 146 M | Israel |